Know Cancer

or
forgot password

A 12 Month, Multi-center, Open-label, Randomized, Controlled Study to Evaluate Efficacy/Safety and Evolution of Renal Function of Everolimus in Co-exposure With Tacrolimus in de Novo Liver Transplant Recipients


Phase 3
18 Years
65 Years
Open (Enrolling)
Both
Liver Transplantation

Thank you

Trial Information

A 12 Month, Multi-center, Open-label, Randomized, Controlled Study to Evaluate Efficacy/Safety and Evolution of Renal Function of Everolimus in Co-exposure With Tacrolimus in de Novo Liver Transplant Recipients

Inclusion Criteria


Inclusion criteria:

- Male or female recipients of a full-size liver allograft, aged 18 to 65 years.

Exclusion criteria:

- Patients with thrombocytopenia (platelets <100,000/mm³), with an absolute neutrophil
count of <1,500/mm³ or leucopenia (leucocytes <3000/mm³), with anemia with Hb < 8g/dl
at time of screening

- Patients with uncontrolled hypercholesterolemia (>330mg/dL; >9mmol/L) or
hypertriglyceridemia (>300 mg/dL; >8.5 mmol/L) at time of screening

- History of malignancy of any organ system within the past 5 years whether or not
there is evidence of local recurrence or metastases, other than non-metastatic basal
or squamous cell carcinoma of the skin or HCC (see next criteria).

- Other protocol-defined inclusion/exclusion criteria may apply

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Estimated glomerular filtration rate (MDRD-4 formula) at Month 12 in de novo liver

Outcome Description:

Immunosuppressive regimen based on everolimus (EVR) in coexposure with tacrolimus (TAC) compared to tacrolimus alone on estimated glomerular filtration rate (MDRD-4 formula) at Month 12 in de novo liver transplant recipients.

Outcome Time Frame:

at 12 months after randomization

Safety Issue:

No

Authority:

United States: Institutional Review Board

Study ID:

CRAD001HDE13

NCT ID:

NCT01551212

Start Date:

May 2012

Completion Date:

Related Keywords:

  • Liver Transplantation
  • Liver transplantation
  • everolimus
  • kidney function

Name

Location